Febrifugine dihydrochloride as a new oral chemotherapeutic agent against visceral leishmaniasis infection. Pandey RK, Ojha R, Devender M, Sebastian P, et al. Exp Parasitol 2022;236-237:108250.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Pandey RK, Ojha R, Devender M, Sebastian P, et al. Febrifugine dihydrochloride as a new oral chemotherapeutic agent against visceral leishmaniasis infection. Exp Parasitol 2022;236-237:108250.
PMID: 35390313